markets is the sole category represented across all 1 tracked stories. Exelixis is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.4.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Inari Medical
markets is the sole category represented across all 1 tracked stories. Exelixis is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 5, the average consequence score sits below the same-window beat average of 6.4. They are less corroborated than the beat average, carrying 2 original sources each against 2.6 for the same window. Inari Medical appears in 1 tracked Finance story from March 14, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 95 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Inari Medical. Shared-story counts are live from our verified record — not editorial picks.
Following the conclusion of the latest earnings season, quantitative analysis reveals a surge in mid-cap healthcare and communication services stocks. Leading the pack are companies like Inari Medical and Ziff Davis, which have demonstrated superior profitability and growth metrics relative to their peers.
Inari Medical is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.